CRMD vs. EXE
CRMD (CorMedix Inc.) and EXE (Expand Energy Corp) are both stocks. CRMD operates in Biotechnology (Healthcare), while EXE operates in Oil & Gas E&P (Energy). Over the past 5 years, CRMD returned 5.32%/yr vs 17.06%/yr for EXE. Their 0.14 correlation means their historical movements had little consistent relationship.
Performance
CRMD vs. EXE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRMD achieves a -35.25% return, which is significantly lower than EXE's -13.81% return.
CRMD
- 1D
- 0.53%
- 1M
- -11.10%
- 6M
- -2.96%
- YTD
- -35.25%
- 1Y
- -35.48%
- 3Y*
- 20.63%
- 5Y*
- 5.32%
- 10Y*
- 0.24%
- ALL TIME*
- -4.54%
EXE
- 1D
- 1.74%
- 1M
- 4.98%
- 6M
- -15.39%
- YTD
- -13.81%
- 1Y
- -7.38%
- 3Y*
- 6.64%
- 5Y*
- 17.06%
- 10Y*
- —
- ALL TIME*
- 20.58%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
CRMD CorMedix Inc. | $7.65M | $7.49M | $10.66M |
| $371.17M | $368.49M | $332.29M |
CRMD vs. EXE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CRMD CorMedix Inc. | -35.25% | 43.58% | 115.43% | -10.90% | -7.25% | -67.73% |
EXE Expand Energy Corp | -13.81% | 14.35% | 33.18% | -14.77% | 62.34% | 53.16% |
Correlation
The correlation between CRMD and EXE is 0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.03 |
Correlation (3Y) Balances recent behavior with more history. | 0.11 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.14 |
Correlation (All Time) Calculated using the full available price history since Feb 10, 2021 | 0.14 |
The correlation between CRMD and EXE shifts across timeframes, from 0.03 (1 year) to 0.14 (all time), reflecting how their relationship changes across market environments.
Fundamentals
CRMD:
$590.74M
EXE:
$21.77B
CRMD:
$1.99
EXE:
$11.59
CRMD:
3.79
EXE:
8.11
CRMD:
1.71
EXE:
1.69
CRMD:
1.60
EXE:
1.15
CRMD:
$400.05M
EXE:
$13.37B
CRMD:
$343.39M
EXE:
$8.44B
CRMD:
$207.97M
EXE:
$6.60B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRMD vs. EXE — Risk / Return Rank
CRMD
EXE
CRMD vs. EXE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CorMedix Inc. (CRMD) and Expand Energy Corp (EXE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRMD | EXE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.32 | ||
| Sortino ratioReturn per unit of downside risk | -0.30 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 0.98 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | -0.62 | -0.26 | -0.35 |
| Martin ratioReturn relative to average drawdown | -0.90 | -0.48 | -0.42 |
Loading charts...
Drawdowns
CRMD vs. EXE - Drawdown Comparison
The maximum CRMD drawdown since its inception was -98.28%, which is greater than EXE's maximum drawdown of -29.69%. Use the drawdown chart below to compare losses from any high point for CRMD and EXE.
Loading charts...
Drawdown Indicators
| CRMD | EXE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.28% | -29.69% | -68.59% |
Max Drawdown (1Y)Largest decline over 1 year | -57.86% | -28.43% | -29.43% |
Max Drawdown (3Y)Largest decline over 3 years | -62.26% | -28.43% | -33.83% |
Max Drawdown (5Y)Largest decline over 5 years | -62.63% | -29.69% | -32.94% |
Max Drawdown (10Y)Largest decline over 10 years | -94.77% | — | — |
Current DrawdownCurrent decline from peak | -84.74% | -22.60% | -62.14% |
Average DrawdownAverage peak-to-trough decline | -77.60% | -11.35% | -66.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.35% | 15.54% | +23.81% |
Volatility
CRMD vs. EXE - Volatility Comparison
CorMedix Inc. (CRMD) has a higher volatility of 13.70% compared to Expand Energy Corp (EXE) at 8.78%. This indicates that CRMD's price experiences larger fluctuations and is considered to be riskier than EXE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRMD | EXE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.70% | 8.78% | +4.92% |
Volatility (6M)Calculated over the trailing 6-month period | 32.59% | 21.67% | +10.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 63.84% | 30.55% | +33.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.16% | 34.89% | +42.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 91.61% | 34.64% | +56.97% |
Dividends
CRMD vs. EXE - Dividend Comparison
CRMD has not paid dividends to shareholders, while EXE's dividend yield for the trailing twelve months is around 3.39%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
CRMD CorMedix Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EXE Expand Energy Corp | 3.39% | 2.89% | 2.45% | 4.70% | 10.16% | 1.74% |
Financials
CRMD vs. EXE - Financials Comparison
This section allows you to compare key financial metrics between CorMedix Inc. and Expand Energy Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRMD vs. EXE - Profitability Comparison
CRMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, CorMedix Inc. reported a gross profit of 105.12M and revenue of 127.43M. Therefore, the gross margin over that period was 82.5%.
EXE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Expand Energy Corp reported a gross profit of 2.33B and revenue of 2.96B. Therefore, the gross margin over that period was 78.6%.
CRMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, CorMedix Inc. reported an operating income of 63.66M and revenue of 127.43M, resulting in an operating margin of 50.0%.
EXE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Expand Energy Corp reported an operating income of 661.00M and revenue of 2.96B, resulting in an operating margin of 22.3%.
CRMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, CorMedix Inc. reported a net income of 38.60M and revenue of 127.43M, resulting in a net margin of 30.3%.
EXE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Expand Energy Corp reported a net income of 522.00M and revenue of 2.96B, resulting in a net margin of 17.6%.
Frequently Asked Questions
CRMD and EXE have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRMD has higher volatility (13.70%) compared to EXE (8.78%). In terms of maximum drawdown, CRMD dropped -98.28% vs EXE's -29.69%.
EXE currently has the higher Sharpe Ratio (-0.24 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRMD and EXE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer